A novel interaction between the human papillomavirus type 16 E2 and E1^E4 proteins leads to stabilization of E2

Virology

Volumn 394, Issue 2, 2009, Pages 266-275

  Davy, Clare ^a   McIntosh, Pauline ^a   Jackson, Deborah J ^a   Sorathia, Rina ^a   Miell, Matthew ^a   Wang, Qian ^a   Khan, Jameela ^a   Soneji, Yasmina ^a   Doorbar, John ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

E1 E4; E2; E4; HPV; Papillomavirus; Type 16

Indexed keywords

CYCLOHEXIMIDE; HUMAN PAPILLOMA VIRUS TYPE 16 E2 PROTEIN; HUMAN PAPILLOMA VIRUS TYPE 16 E4 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SOLUBILITY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DNA, VIRAL; DNA-BINDING PROTEINS; ESCHERICHIA COLI; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; ONCOGENE PROTEINS, VIRAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 70449095899     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.035     Document Type: Article

References (44)

1. Antson A.A., Burns J.E., Moroz O.V., Scott D.J., Sanders C.M., Bronstein I.B., Dodson G.G., Wilson K.S., and Maitland N.J. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 403 6771 (2000) 805-809
2. Bell I., Martin A., and Roberts S. The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. J. Virol. 81 11 (2007) 5437-5448
3. Bellanger S., Demeret C., Goyat S., and Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75 16 (2001) 7244-7251
4. Davy C.E., Jackson D.J., Wang Q., Raj K., Masterson P.J., Fenner N.F., Southern S., Cuthill S., Millar J.B., and Doorbar J. Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J. Virol. 76 19 (2002) 9806-9818
5. Davy C.E., Ayub M., Jackson D.J., Das P., McIntosh P., and Doorbar J. HPV16 E1-E4 protein is phosphorylated by Cdk2/cyclin A and relocalizes this complex to the cytoplasm. Virology 349 1 (2006) 230-244
6. Davy C.E., Jackson D.J., Raj K., Peh W.L., Southern S.A., Das P., Sorathia R., Laskey P., Middleton K., Nakahara T., Wang Q., Masterson P.J., Lambert P.F., Cuthill S., Millar J.B., and Doorbar J. Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J. Virol. 79 7 (2005) 3998-4011
7. Day P.M., Roden R.B., Lowy D.R., and Schiller J.T. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 72 1 (1998) 142-150
8. Donaldson M.M., Boner W., and Morgan I.M. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81 8 (2007) 4338-4342
9. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond) 110 5 (2006) 525-541
10. Doorbar J., Ely S., Sterling J., McLean C., and Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352 6338 (1991) 824-827
11. Doorbar J., Ely S., Coleman N., Hibma M., Davies D.H., and Crawford L. Epitope-mapped monoclonal antibodies against the HPV16E1-E4 protein. Virology 187 1 (1992) 353-359
12. Doorbar J., Foo C., Coleman N., Medcalf L., Hartley O., Prospero T., Napthine S., Sterling J., Winter G., and Griffin H. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 238 1 (1997) 40-52
13. Doorbar J., Elston R.C., Napthine S., Raj K., Medcalf E., Jackson D., Coleman N., Griffin H.M., Masterson P., Stacey S., Mengistu Y., and Dunlop J. The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J. Virol. 74 21 (2000) 10081-10095
14. Frangioni J.V., and Neel B.G. Solubilization and purification of enzymatically active glutathione-S-transferase (Pgex) fusion proteins. Anal. Biochem. 210 1 (1993) 179-187
15. Gagnon D., Joubert S., Senechal H., Fradet-Turcotte A., Torre S., and Archambault J. Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of the bromodomain-containing protein 4 (Brd4). J. Virol. 83 9 (2009) 4127-4139
16. Gammoh N., Grm H.S., Massimi P., and Banks L. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol. 80 4 (2006) 1787-1797
17. Grm H.S., Massimi P., Gammoh N., and Banks L. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24 33 (2005) 5149-5164
18. Hibma M.H., Raj K., Ely S.J., Stanley M., and Crawford L. The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2. Eur. J. Biochem. 229 2 (1995) 517-525
19. Howley P.M., and Lowy D.R. Papillomaviruses. In: Fields B.N., Knipe D.M., Howley P.M., and Griffin D.E. (Eds). "Virology" 2 (2006), Lippincott Williams and Wilkins, Philadelphia, New York 2299-2354 2 vols.
20. Ilves I., Kivi S., and Ustav M. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites. J. Virol. 73 5 (1999) 4404-4412
21. Keen N., Elston R., and Crawford L. Interaction of the E6 Protein of Human Papillomavirus with Cellular Proteins. Oncogene 9 5 (1994) 1493-1499
22. Klumpp D.J., and Laimins L.A. Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology 257 1 (1999) 239-246
23. Lee A.Y., and Chiang C.M. Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J. Biol. Chem. 284 5 (2009) 2778-2786
24. McIntosh P.B., Martin S.R., Jackson D.J., Khan J., Isaacson E.R., Calder L., Raj K., Griffin H.M., Wang Q., Laskey P., Eccleston J.F., and Doorbar J. Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1-E4 protein and provides a molecular basis for its accumulation. J. Virol. 82 16 (2008) 8196-8203
25. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., and McBride A.A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80 19 (2006) 9530-9543
26. Nakahara T., Peh W.L., Doorbar J., Lee D., and Lambert P.F. Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 79 20 (2005) 13150-13165
27. Okoye A., Cordano P., Taylor E.R., Morgan I.M., Everett R., and Campo M.S. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res. 108 1-2 (2005) 1-14
28. Parish J.L., Bean A.M., Park R.B., and Androphy E.J. ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 24 6 (2006) 867-876
29. Peh W.L., Brandsma J.L., Christensen N.D., Cladel N.M., Wu X., and Doorbar J. The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J. Virol. 78 4 (2004) 2142-2151
30. Penrose K.J., and McBride A.A. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 74 13 (2000) 6031-6038
31. Raj K., Berguerand S., Southern S., Doorbar J., and Beard P. E1 empty set E4 protein of human papillomavirus type 16 associates with mitochondria. J. Virol. 78 13 (2004) 7199-7207
32. Roberts S., Ashmole I., Rookes S.M., and Gallimore P.H. Mutational analysis of the human papillomavirus type 16 E1-E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments. J. Virol. 71 5 (1997) 3554-3562
33. Schweiger M.R., You J., and Howley P.M. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J. Virol. 80 9 (2006) 4276-4285
34. Spalholz B.A., Yang Y.C., and Howley P.M. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell 42 1 (1985) 183-191
35. Stanley M.A., Browne H.M., Appleby M., and Minson A.C. Properties of a non-tumorigenic human cervical keratinocyte cell-line. Int. J. Cancer 43 4 (1989) 672-676
36. Walboomers J., Jacobs M., Manos M.M., Bosch F., Kummer J., Shah K., Snijders P., Peto J., Meijer C., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 1 (1999) 12-19
37. Wang Q., Griffin H., Southern S., Jackson D., Martin A., McIntosh P., Davy C., Masterson P.J., Walker P.A., Laskey P., Omary M.B., and Doorbar J. Functional analysis of the human papillomavirus type 16 E1( wedge )E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J. Virol. 78 2 (2004) 821-833
38. Wang Q., Kennedy A., Das P., McIntosh P.B., Howell S.A., Isaacson E.R., Hinz S.A., Davy C., and Doorbar J. Phosphorylation of the human papillomavirus type 16 E1-E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability. J. Virol. 83 8 (2009) 3668-3683
39. Wang X., Naidu S.R., Sverdrup F., and Androphy E.J. Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J. Virol. 83 5 (2009) 2274-2284
40. Wilson R., Fehrmann F., and Laimins L.A. Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 79 11 (2005) 6732-6740
41. Wilson R., Ryan G.B., Knight G.L., Laimins L.A., and Roberts S. The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology 362 2 (2007) 453-460
42. Yang L., Li R., Mohr I.J., Clark R., and Botchan M.R. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353 6345 (1991) 628-632
43. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 3 (2004) 349-360
44. Zhao K.N., Hengst K., Liu W.J., Liu Y.H., Liu X.S., McMillan N.A., and Frazer I.H. BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology 272 2 (2000) 382-393